Associate Director, Commercial Training Lead (Bilingual German/English

Join to apply for the Associate Director, Commercial Training Lead role at Alnylam Pharmaceuticals This role is considered Hybrid. Role Overview We are looking for a passionate and strategic Commercial Training Lead , fluent in English and German (written and language) to elevate the capabilities of our international commercial field teams. In this high-impact Associate Director role, you will lead the design, delivery, and evaluation of innovative training programs that drive performance, align with global strategy, and foster a culture of continuous learning. You’ll collaborate cross-functionally with Commercial, Medical, Compliance, and Marketing teams across diverse international markets to ensure consistent, high-quality training experiences. Key Responsibilities Training Strategy French or Spanish is a plus. Proven experience as a Key Account Manager in the pharmaceutical industry. Strong foundation in adult learning principles and instructional design methodologies. Demonstrated expertise in performance and in-field coaching. Bachelor’s degree or equivalent; strong academic and scientific background preferred. Experience designing and delivering training programs, including digital content. Skilled in managing vendors and leading Initial Training Programmes (ITP’s). Minimum 5 years of commercial experience in the pharmaceutical sector. Excellent facilitation, presentation, and communication skills. Proven ability to collaborate with senior leadership to drive commercial success. Deep understanding of therapeutic areas and a passion for learning and development. Proficient in MS Office (Word, Excel, PowerPoint); digital content and SEO knowledge is a bonus. About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America\’s Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Alnylam is an equal employment opportunity employer and welcomes applications from diverse candidates. #J-18808-Ljbffr